天美影院

Theranostics-Care-Pathway key visual

Theranostics for personalized cancer care

Partnering together for the future of precision oncology

Theranostics at a glance

Graphic of a globe, cancer incidence rates are rising

Cancer incidence rates are rising

Cancer incidence rates continue to rise worldwide with an expectation of 28 million new cases by 2040.1 Taking this outlook into consideration, we are reminded of the need to prioritize precision oncology for everyone, everywhere.聽

Theranostics enables precision oncology

Theranostics enables precision oncology

Theranostics (i.e., "therapy" + "diagnostics") is an innovative approach to personalized cancer care that involves the use of molecular imaging (e.g., PET/CT and SPECT/CT) and radiopharmaceuticals to tailor treatments to an individual patient. It involves the combination of one diagnostic radioactive drug to "see" the disease and a second therapeutic radioactive drug to deliver therapy to "treat" the disease.

The future of theranostics

The future of theranostics

From new radiopharmaceutical therapy development to expanding clinical indications, the adoption of theranostics into clinical practice continues to grow. This growth is triggering the upscaling of existing and new theranostics centers to meet the demand for this type of personalized, predictive, and precise cancer treatment.

Theranostics care pathway

Your trusted partner in theranostics

There is no one-size-fits-all approach to theranostics, so no matter where your institution is on its theranostics journey, we want to empower you with the tools you need to plan, implement, and expand your program to meet the demands of tomorrow.

Establish an innovative theranostics program with our comprehensive value chain and trusted expertise. We are committed to personalizing theranostics solutions for you, so you can focus on personalizing care for patients.聽

Graphic for Theranostics implementation checklist widget - step 1 Regulatory

Implementing a theranostics program into an existing practice requires a comprehensive set of considerations including technology investments, staff training, regulatory compliance, strategic partnerships, and financial planning.聽

Explore our educational resource hub to learn how to build a successful theranostics program.

How other providers are integrating theranostics into care

Nebraska Cancer Specialists in the midwestern region of the United States serves as a model of excellence in theranostics.

Theranostics center of excellence: transforming oncology care

Nebraska Cancer Specialists in the midwestern region of the United States serves as a model of excellence in theranostics. While caring for the local community and attracting patients from across the country, the center also operates an extensive clinical trials program.

210 PET Theranostics

Building a theranostics program: one non-academic outpatient center's approach

Located in Cary, NC, 210 PET Imaging is one of the first non-academic outpatient centers in the North Carolina Research Triangle to establish its own theranostics program. Their team shares their experience and offers recommendations on gaining support from administrators and referring physicians.

NMNS Theranostics

Theranostics offers personalized care for prostate cancer

Professor Joseph R. Osborne, MD, PhD, Chief of Molecular Imaging and Therapeutics, and Professor of Radiology at a leading academic institution鈥檚 hospital in New York City, NY, discusses theranostics and its rapidly expanding role in prostate cancer care.

Patient outcomes 

Every patient's theranostics journey is different. Watch these patient stories to learn more. 

1
2
3
4
5
Subscription Button Icon
Be the first to know about our events, training, and news